Application of Individualized Treatment Strategies for CLL/SLL

In this slideset and commentary CLL/SLL experts discuss multiple new drug approvals promising clinical trials novel mechanisms of action and how to integrate these new approaches into individual patient management.

Share

Program Content

Activities

CLL 2022 Downloadable Slides 1
Case Discussion: Recent Data on Advances in Treatment for CLL
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 07, 2022

Expires: June 06, 2023

CLL 2022 Downloadable Slides 2
Similarities and Differences of CLL/SLL Agents by Drug Class
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 07, 2022

Expires: June 06, 2023

CLL 2022 Downloadable Slides 3
CLL/SLL: Putting It All Together
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 07, 2022

Expires: June 06, 2023

Activities

Recent CLL Results
How I Individualize Therapy for Patients With Chronic Lymphocytic Leukemia
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: July 25, 2022

Expires: July 24, 2023

Faculty

cover img faculity

Farrukh Awan, MD, MS

Associate Professor of Internal Medicine
Division of Hematology
The Ohio State University Comprehensive Cancer Center
Arthur G. James Cancer Hospital and Richard J. Solove Research Institute
Columbus, Ohio

cover img faculity

Asher Chanan-Khan, MD

Associate Professor of Oncology
Attending Physician
, Department of Medicine
Member, Department of Pharmacology and Therapeutics
Roswell Park Cancer Institute
Buffalo, New York

cover img faculity

William G. Wierda, MD, PhD

Associate Professor of Medicine
Department of Leukemia
The University of Texas
M.D. Anderson Cancer Center
Houston, Texas

Provided by

ProCE Banner

Supporters

Supported by educational grants from

AbbVie Inc.

AstraZeneca

BeiGene

Janssen administered by Scientific Affairs

Pharmacyclics an AbbVie Company